This past week, the TSX has been riding a wave of optimism, buoyed by expectations of potential interest-rate cuts in the United States. However, the index recently snapped an impressive eight-session winning streak after data revealed that Canada’...
Jonathon Brown
|
August 22, 2024
|
It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis
|
June 25, 2021
|
Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis
|
February 7, 2020
|
Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...
Fredrick William
|
May 15, 2020
|
Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon
|
September 27, 2023
|
(Peniaphobia: fear of poverty) This weekend, newsletter writers the world over are scrambling to explain to their paid subscribers why they are now showing losses in portfolios that were supposed to be showing gains, and especially because it was only two weeks ago t...
Streetwise Reports
|
March 3, 2020
|
A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. You don't often hear about it, but bladder cancer is the sixth most common cancer in the U.S., with approximately 80,000 cases reported every year, and some 600,000 Americans living in ...
Streetwise Reports
|
November 13, 2019
|
Legendary investor Rick Rule of Sprott USA , sat down with us on very candid interview to discuss the deep values that Sprott is focusing on for their clients. We shall discuss base metals, precious metals, royalty and streaming, and prospect/project generators. Mr. Rule ...
Maurice Jackson
|
May 27, 2019
|
Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills
|
November 15, 2019
|
The following is a transcription of the above video, and The Market Online has edited it for clarity . The Market Online recently caught up with NurExone Biologic Inc (TSXV:NRX) , a revolutionary biopharmaceutical company developing regenerative medicine therapies,...
Lyndsay Malchuk
|
July 10, 2024
|